Experienced in Immune Thrombocytopenic Purpura (ITP)

Wojciech Homenda

Slupsk, PM, PL 
Experienced in Immune Thrombocytopenic Purpura (ITP)
Slupsk, PM, PL 
OverviewLocationsClinical Research

Overview

Wojciech Homenda practices in Slupsk, Poland. Mr. Homenda is rated as an Experienced expert by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Ventricular Fibrillation, Adult Immune Thrombocytopenia, Purpura, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

His clinical research consists of co-authoring 17 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 1 clinical trial in the study of Immune Thrombocytopenic Purpura (ITP).

Gender
Male

Locations

Slupsk, PM, Poland
Other Locations
Bialystok, PD, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options
Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options
Enrollment Status: Completed
Publish Date: July 10, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug
Study Drug: Fostamatinib
Study Phase: Phase 3
View 1 Less Clinical Trial

17 Total Publications

A novel method of diagnosing and monitoring cardiac arrhythmias in patients with chronic lymphocytic leukemia treated with ibrutinib.
A novel method of diagnosing and monitoring cardiac arrhythmias in patients with chronic lymphocytic leukemia treated with ibrutinib.
Journal: Polish archives of internal medicine
Published: July 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Homenda's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile